Changes in glucose homeostasis from baseline to end-of-follow-up.

<p>Changes in glucose homeostasis from baseline to end-of-follow-up.</p

Changes in BMI category from baseline to end-of-follow-up.

<p>Changes in BMI category from baseline to end-of-follow-up.</p

Metabolic profiles of WS patients not known for type 2 DM (30 out of 31) at baseline and end-of-follow-up.

<p>Metabolic profiles of WS patients not known for type 2 DM (30 out of 31) at baseline and end-of-follow-up.</p

Changes in CPGI relative to changes in MI in progressors (red; n = 8) and non-progressors (blue; n = 8).

<p>The lines represent the prediction line and the lower and upper limits of the 95% confidence interval of the regression between CPGI and MI as derived from a reference population with NFG/NGT. CPGI = C-peptidogenic Index; MI = Composite Insulin Sensitivity Index or Matsuda Index; NFG = normal fasting glucose; NGT = normal glucose tolerance.</p